Results 111 to 120 of about 7,260 (206)

Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication. [PDF]

Med Gas Res
Soltani G, Shalaby WS, Razeghinejad R.
europepmc   +1 more source

Systemic adverse drug events to topical prostaglandin analogs for treating glaucoma: a retrospective focused pharmacovigilance study. [PDF]

BMC Ophthalmol
Sridharan K.
europepmc   +1 more source

Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions. [PDF]

Drug Des Devel Ther
Chatzimichail E, Christodoulaki E, Konstas PAG, Tsiropoulos GN, Amaxilati E, Gugleta K, Gatzioufas Z, Panos GD.   +7 more
europepmc   +1 more source

Evidence in Practice: A Review of Real-Life Studies and Clinical Experience with the Preservative-Free Tafluprost (0.0015%) and Timolol (0.5%) Fixed-Dose Combination. [PDF]

Clin Ophthalmol
Hollo G.
europepmc   +1 more source

The effects of topical latanoprost 0.005% treatment on microvascular changes in the optic nerve head and macula. [PDF]

Indian J Ophthalmol
Yıldırım Erdal BD, Hondur G, Bayraktar S, Elgin U, Şen E.   +4 more
europepmc   +1 more source

Relationship Between Intraocular Pressure and the True Rate of Functional and Structural Progression in the United Kingdom Glaucoma Treatment Study. [PDF]

Invest Ophthalmol Vis Sci
Montesano G, Rabiolo A, Ometto G, Crabb DP, Garway-Heath DF.   +4 more
europepmc   +1 more source

Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues. [PDF]

PLoS One
Gershon R, Vishnevskia-Dai V.
europepmc   +1 more source

Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study. [PDF]

J Glaucoma
Aihara M, Lu F, Ikeda T, Odani-Kawabata N.   +3 more
europepmc   +1 more source

Effect of latanoprost on choroidal thickness in patients with newly diagnosed primary open-angle glaucoma. [PDF]

North Clin Istanb
Buyukmurat N, Karadag E, Ozbek H.
europepmc   +1 more source

Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database. [PDF]

Ther Adv Drug Saf
Wu SN, Huang C, Wang YQ, Li X, Zhang SQ, Chen XD, Qin DY, Zhu L, Wen JY, Luo NC, Hu J, Liu Z.   +11 more
europepmc   +1 more source